Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients

Parkinsonism and Related Disorders

Volumn 20, Issue 8, 2014, Pages 850-854

  Picillo, Marina ^a,b   Erro, Roberto ^c   Amboni, Marianna ^b,d   Longo, Katia ^d   Vitale, Carmine ^d,e   Moccia, Marcello ^a   Pierro, Angela ^b   Scannapieco, Sara ^b   Santangelo, Gabriella ^f   Spina, Emanuele ^a   Orefice, Giuseppe ^a   Barone, Paolo ^b   Pellecchia, Maria Teresa ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IDC Hermitage Capodimonte   (Italy)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Dopaminergic therapy; Gender; Gender differences; Non motor symptoms; Parkinson's disease; Progression

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; ANTIPARKINSON AGENT;

ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; CONSTIPATION; DAYTIME SOMNOLENCE; DELUSION; DIAPHORESIS; DISEASE PREDISPOSITION; DIZZINESS; EDEMA; EMOTIONAL DISORDER; FALLING; FECES INCONTINENCE; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; INSOMNIA; INTESTINE MOTILITY; LIBIDO; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MEMORY DISORDER; MOTOR DYSFUNCTION; NOCTURIA; NON MOTOR SYMPTOM; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTLESS LEGS SYNDROME; RISK FACTOR; SEX DIFFERENCE; SMELLING DISORDER; SYMPTOMATOLOGY; TASTE DISORDER; VIVID DREAM; VOMITING; WEIGHT CHANGE; AGED; COMPLICATION; MIDDLE AGED; SEXUAL DEVELOPMENT;

AGED; ANTIPARKINSON AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEX CHARACTERISTICS;

EID: 84905231065     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.04.023     Document Type: Article

References (30)

1. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T.P., et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009, 24:1641-1649.
2. Antonini A., Barone P., Marconi R., Morgante L., Zappulla S., Pontieri F.E., et al. The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. JNeurol 2012, 259:2621-2631.
3. Aarsland D., Larsen J.P., Tandberg E., Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. JAm Geriatr Soc 2000, 48:938-942.
4. Seppi K., Weintraub D., Coelho M., Perez-Lloret S., Fox S.H., Katzenschlager R., et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011, 26:S42-S80.
5. Kim H.J., Park S.Y., Cho Y.J., Hong K.S., Cho J.Y., Seo S.Y., et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. JNeurol Sci 2009, 287:200-204.
6. Pacchetti C., Manni R., Zangaglia R., Mancini F., Marchioni E., Tassorelli C., et al. Relationship between hallucinations, delusions, and rapid eye movement Sleep behavior disorder in Parkinson's disease. Mov Disord 2005, 20:1439-1448.
7. Erro R., Picillo M., Vitale C., Amboni M., Moccia M., Longo K., et al. Non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients. JNeurol Neurosurg Psychiatry 2013, 84(1):14-17.
8. Picillo M., Amboni R., Erro R., Longo K., Vitale C., Moccia M., et al. Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease. JNeurol 2013, 260(11):2849-2855.
9. Miller I.N., Cronin-Golomb A. Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord 2010, 25(16):2695-2703.
10. Solla P., Cannas A., Ibba F.C., Loi F., Corona M., Orofino G., et al. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease. JNeurol Sci 2012, 323(1-2):33-39. 15.
11. Martinez-Martin P., Falup Pecurariu C., Odin P., Van Hilten J.J., Antonini A., Rojo-Abuin J.M., et al. JNeurol 2012, 259:1639-1647.
12. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
13. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
14. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
15. Lang A.E., Riley D.E., Bergeron C. Cortical-basal ganglionic degeneration. Neurodegenerative diseases 1994, 877-894. WB Saunders, Philadelphia. D.B. Calne (Ed.).
16. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47:1113-1124.
17. Fahn S., Elton R.L. UPDRS program members. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, vol. 2:153-163. Macmillan Healthcare Information, Florham Park N.
18. Chaudhuri K.R., Martinez-Martin P., Schapira A.H.V., Stocchi F., Sethi K., Odin P., et al. An international multicentre pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006, 21:916-923.
19. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of Levodopa Dose Equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2685.
20. Kalf J.G., Munneke M., van den Engel-Hoek L., de Swart B.J., Borm G.F., Bloem B.R., et al. Pathophysiology of diurnal drooling in Parkinson's disease. Mov Disord 2011, 26:1670-1676.
21. Guo X., Song W., Chen K., Chen X., Zheng Z., Cao B., et al. Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease - a study from Southwest China. Parkinson Relat Disord 2009, 4:S81-S84.
22. Valkoa P.O., Waldvogela D., Wellera M., Bassetti C.L., Held U., Baumann C.R. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 2010, 17:1428-1436.
23. Nirenberg M.J., Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006, 21:524-529.
24. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease. A cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
25. Lyons K., Hubble J., Troster A., Pahwa R., Koller W.C. Gender differences in Parkinson's disease. Clin Neuropharmacol 1998, 21:118-121.
26. Haaxma C.A., Bloem B.R., Borm G.F., Oyen W.J., Leenders K.L., Eshuis S., et al. Gender differences in Parkinson's disease. JNeurol Neurosurg Psychiatry 2007, 78:819-824.
27. Zoccolella A., Savarese M., Lamberti P., Manni R., Pacchetti C., Logroscino G. Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev 2011, 15:41-50.
28. Picillo M., Rocco M., Barone P. Dopamine receptor agonists and depression in Parkinson's disease. Park Relat Disord 2009, 4:S81-S84.
29. Solimeo S. Sex and gender in older adults' experience of Parkinson's disease. JGerontol B Psychol Sci Soc Sci 2008, 63:S42-S48.
30. Chaudhuri K.R., Martinez-Martin P., Brown R.G., Sethi K., Stocchi F., Odin P., et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007, 22:1901-1911.